|
Female/male (n)
|
9/7
|
4/4
|
7/1
|
20/12
|
166/149
|
|
Age (y)
|
49.4 ± 8.5
|
49.3 ± 5.8
|
50.5 ± 9.0
|
49.7 ± 7.8
|
49.3 ± 10.2
|
|
BMI (kg/m2)
|
28.0 ± 4.9
|
28.2 ± 4.8
|
27.9 ± 3.8
|
28.0 ± 4.5
|
27.4 ± 4.9
|
|
Serum creatinine (μmol/L)
|
88 ± 18.9
|
91 ± 12.8
|
85 ± 17.1
|
88 ± 6.7
|
88 ± 15.1
|
|
Serum uric acid (μmol/L)
|
329 ± 95.3
|
335 ± 65.6
|
386 ± 173.2
|
338 ± 87.1
|
340 ± 91.2
|
|
Fasting blood glucose (mmol/L)
|
5.3 ± 0.9
|
5.7 ± 1.1
|
5.5 ± 0.9
|
5.4 ± 0.9
|
5.6 ± 1.1
|
|
Serum cholesterol (mmol/L)
|
5.5 ± 0.8
|
6.0 ± 1.2
|
5.3 ± 0.7
|
5.6 ± 0.9
|
5.6 ± 1.0
|
|
Serum potassium (mmol/L)
|
4.1 ± 0.3
|
4.2 ± 0.4
|
4.2 ± 0.5
|
4.2 ± 0.4
|
4.1 ± 0.3
|
|
Serum sodium (mmol/L)
|
141 ± 2.4
|
140 ± 3.5
|
138 ± 2.2
|
140 ± 2.8
|
140 ± 0.3
|
|
Potassium supplementation (n)
|
1
|
0
|
2
|
3 (9.4%)
|
31 (9.8%)
|
|
Cerebrovascular disorder (n)
|
1
|
0
|
0
|
1 (3.1%)
|
17 (5.4%)
|
|
Diabetes (n)
|
1
|
1
|
1
|
3 (9.4%)
|
36 (11.4%)
|
|
Gestational hypertension (n)
|
3
|
1
|
2
|
6 (18.8%)
|
44 (14.0%)
|
